Literature DB >> 12239911

Adenosquamous carcinoma of the gallbladder.

Motoi Kondo1, Keizo Dono, Masato Sakon, Junzo Shimizu, Hiroaki Nagano, Shoji Nakamori, Koji Umeshita, Ken-ichi Wakasa, Morito Monden.   

Abstract

BACKGROUND/AIMS: Adenosquamous carcinoma of the gallbladder is relatively rare. Its biological behavior and optimal surgical procedure are still controversial.
METHODOLOGY: Clinicopathological factors and proliferating cell nuclear antigen expression were studied in four stage IV adenosquamous carcinoma patients who underwent curative surgery between June 1987 and April 2000, comparing those of 14 stage IV adenocarcinoma patients at the same period.
RESULTS: Preoperative radiological evaluation disclosed a mass invading to the adjacent organs in all cases (liver in 3 cases, and liver and stomach in one case). Three patients (case 1, 2 and 3: well-differentiated adenosquamous carcinomas) were all alive without recurrence in 10, 7, and 2 years after surgery. In contrast, the remaining patient (case 4: moderately differentiated adenosquamous carcinoma) with positive pathologic factors (lymph node metastasis, vascular invasion, etc) deceased one year after surgery due to peritoneal dissemination. When survival rate of adenosquamous carcinoma was compared, the prognosis of adenosquamous carcinoma was significantly better than that of adenocarcinoma (P = 0.0103). Comparison of pathological factors revealed that the frequency of lymph node metastasis was significantly higher in adenocarcinoma than in adenosquamous carcinoma (P = 0.004). Consistent with these findings, the positivity rate of proliferating cell nuclear antigen labeling was significantly lower in squamous carcinoma component, compared with adenosquamous component (P < 0.0001) or adenocarcinoma (P < 0.0001).
CONCLUSIONS: Even in patients with stage IV adenosquamous carcinoma of the gallbladder, a long-term survival may be obtained by curative surgery if the squamous component is predominant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239911

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  20 in total

1.  Squamous Cell and Adenosquamous Carcinoma of Gall Bladder: a Clinicopathological Study of 8 Cases Isolated in 94 Cancers.

Authors:  Hanni Vasudev Gulwani; Suneeta Gupta; Sukhpreet Kaur
Journal:  Indian J Surg Oncol       Date:  2017-05-03

2.  Primary Pure Keratinising Squamous Cell Carcinoma: A Rare Malignancy with Aggressive Behaviour.

Authors:  Mansi Chandna; Leela Pant; Malini Garg; Garima Singh; Sompal Singh
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

Authors:  J Li; Z Yang; Q Zou; Y Yuan; J Li; L Liang; G Zeng; S Chen
Journal:  Clin Transl Oncol       Date:  2013-06-21       Impact factor: 3.405

4.  Squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder: an immunohistochemistry study of prognostic markers.

Authors:  Jiequn Li; Zhu-Lin Yang; Qiong Zou; Yuan Yuan; Jinghe Li; Lufeng Liang; Guixiang Zhen; Senlin Chen
Journal:  Pathol Oncol Res       Date:  2013-09-28       Impact factor: 3.201

5.  Prothymosin-α and parathymosin expression predicts poor prognosis in squamous and adenosquamous carcinomas of the gallbladder.

Authors:  Kang Chen; Li Xiong; Zhuling Yang; Shengfu Huang; Rong Zeng; Xiongying Miao
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

6.  ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Jinghe Li; Zhu-Lin Yang; Xuebao Ren; Qiong Zou; Yuan Yuan; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Tumour Biol       Date:  2012-10-13

7.  A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.

Authors:  Zhulin Yang; Zhi Yang; Qiong Zou; Yuan Yuan; Jinghe Li; Daiqiang Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Int J Clin Oncol       Date:  2013-04-17       Impact factor: 3.402

8.  Nectin-2 and DDX3 are biomarkers for metastasis and poor prognosis of squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

Authors:  Xiongying Miao; Zhu-Lin Yang; Li Xiong; Qiong Zou; Yuan Yuan; Jinghe Li; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

9.  ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.

Authors:  Jinghe Li; Zhu-lin Yang; Xuebao Ren; Qiong Zou; Yuan Yuan; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  J Mol Histol       Date:  2013-08-07       Impact factor: 2.611

10.  The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.

Authors:  Luyao Liu; Zhu-Lin Yang; Chunwei Wang; Xiongying Miao; Zhiyu Liu; Daiqiang Li; Qiong Zou; Jinghe Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  Pathol Oncol Res       Date:  2015-12-03       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.